ERIN STINNETT: Open Payments
NPI 1164932497 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 21 payments from 8 companies in 2025. Trend: 2023 $338 · 2024 $399 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| OPKO Pharmaceuticals, LLC | 4 | $66 |
| Calliditas Therapeutics US Inc. | 3 | $66 |
| Travere Therapeutics, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: JYNARQUE, RAYALDEE, TARPEYO, Kerendia, FARXIGA, FUROSCIX, ACCRUFER.
Industry payments across TN — which companies pay providers there.
